# JYLAMVO
> **NDA212479** · New Drug Application · Sponsor: SHORLA · Approved 2022-11-29
## Drug
- **FDA Application Number:** NDA212479
- **Application type:** New Drug Application
- **Brand name:** JYLAMVO
- **Generic name:** METHOTREXATE
- **Active ingredients:** METHOTREXATE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SHORLA
- **Manufacturer:** SHORLA ONCOLOGY INC.
- **First approval:** 2022-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212479)
---
*MORVS · CC0 1.0*